Role of complex carbohydrates in human immunodeficiency virus type 1 infection and resistance to antibody neutralization - Wikidata - wikimedia - TriplyDB

Role of complex carbohydrates in human immunodeficiency virus type 1 infection and resistance to antibody neutralization

Role of complex carbohydrates in human immunodeficiency virus type 1 infection and resistance to antibody neutralization

http://www.wikidata.org/entity/Q39723388

about

Glycan masking of Plasmodium vivax Duffy Binding Protein for probing protein binding function and vaccine development Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120 Structural basis for diverse N-glycan recognition by HIV-1–neutralizing V1–V2–directed antibody PG16 Antibody 8ANC195 Reveals a Site of Broad Vulnerability on the HIV-1 Envelope Spike Natively glycosylated HIV-1 Env structure reveals new mode for antibody recognition of the CD4-binding site Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies Computational prediction of broadly neutralizing HIV-1 antibody epitopes from neutralization activity data Molecular dynamics analysis of antibody recognition and escape by human H1N1 influenza hemagglutinin.HIV-1 Glycan Density Drives the Persistence of the Mannose Patch within an Infected Individual.Stabilized HIV-1 envelope glycoprotein trimers for vaccine use.Computational analysis of anti-HIV-1 antibody neutralization panel data to identify potential functional epitope residues A human antibody to the CD4 binding site of gp120 capable of highly potent but sporadic cross clade neutralization of primary HIV-1.Multi-Parameter Exploration of HIV-1 Virus-Like Particles as Neutralizing Antibody Immunogens in Guinea Pigs, Rabbits and Macaques The genotype of early-transmitting HIV gp120s promotes α (4) β(7)-reactivity, revealing α (4) β(7) +/CD4+ T cells as key targets in mucosal transmission.Isolation of a monoclonal antibody that targets the alpha-2 helix of gp120 and represents the initial autologous neutralizing-antibody response in an HIV-1 subtype C-infected individual.Antibody to gp41 MPER alters functional properties of HIV-1 Env without complete neutralization The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade.Envelope deglycosylation enhances antigenicity of HIV-1 gp41 epitopes for both broad neutralizing antibodies and their unmutated ancestor antibodies.Expression-system-dependent modulation of HIV-1 envelope glycoprotein antigenicity and immunogenicity Partial enzymatic deglycosylation preserves the structure of cleaved recombinant HIV-1 envelope glycoprotein trimers.Stabilized HIV-1 envelope glycoprotein trimers lacking the V1V2 domain, obtained by virus evolution.Glycoform and net charge heterogeneity in gp120 immunogens used in HIV vaccine trials.Induction of immunity to human immunodeficiency virus type-1 by vaccination.Prime-boost immunization of rabbits with HIV-1 gp120 elicits potent neutralization activity against a primary viral isolate.Glycosylation of the core of the HIV-1 envelope subunit protein gp120 is not required for native trimer formation or viral infectivity.HIV-1 envelope glycan moieties modulate HIV-1 transmission.Rapid high-level production of functional HIV broadly neutralizing monoclonal antibodies in transient plant expression systems Evidence for a continuous drift of the HIV-1 species towards higher resistance to neutralizing antibodies over the course of the epidemic.Polyreactivity and autoreactivity among HIV-1 antibodies.A chimeric HIV-1 envelope glycoprotein trimer with an embedded granulocyte-macrophage colony-stimulating factor (GM-CSF) domain induces enhanced antibody and T cell responses.Enzyme digests eliminate nonfunctional Env from HIV-1 particle surfaces, leaving native Env trimers intact and viral infectivity unaffected.Directed evolution of a yeast-displayed HIV-1 SOSIP gp140 spike protein toward improved expression and affinity for conformational antibodies.Role of immune mechanisms in induction of HIV-1 broadly neutralizing antibodies.Characterization of glycosylation profiles of HIV-1 transmitted/founder envelopes by mass spectrometry.Lack of protection following passive transfer of polyclonal highly functional low-dose non-neutralizing antibodies Mechanism of neutralization by the broadly neutralizing HIV-1 monoclonal antibody VRC01.Rescue of HIV-1 broad neutralizing antibody-expressing B cells in 2F5 VH x VL knockin mice reveals multiple tolerance controls.Enhanced HIV-1 neutralization by antibody heteroligation

P2860

Q21558777-758133F7-B602-45F4-A2F5-51216835C9FC Q27319450-9A1D0833-B6E7-4067-924A-C9B33C56227A Q27674878-2FCA402A-6A5D-4598-BED6-6B6193163F24 Q27678306-23F965E9-D012-4D05-9845-6B357D7DED92 Q27678312-80D2A128-E1A4-42B2-B004-121E6147684F Q27683540-8B464C8F-73B0-4C72-9F06-7C1345BA1B3C Q27728037-7C1376CB-EDFE-4CD9-9979-04DA8F700E75 Q28263932-1CBAA0AC-6B13-4C5E-8241-BAB1D4B35BDF Q28535583-B67B1948-14B2-4127-BCBC-FEB4E6CD5574 Q30375271-56EB6D2B-E971-46AD-A766-62CA29ADA344 Q30393763-8EDE2225-18FC-4D54-9380-9664A3B7A878 Q30490942-39F5EA64-364F-467F-B453-5238A8C5C415 Q30644992-E46CA8A7-48E3-4E9F-BB4A-9C2F0F9A08DC Q31132248-9D235AEA-6235-4553-A66C-DBFA71B36048 Q33683203-6BB37377-14F5-4E38-8EA4-902E93E5B45B Q33839456-6EA162A7-DB98-4426-8797-6DD4FBF093CD Q33912373-3E0BD70A-E743-4C00-81A7-823AF3151E00 Q33946158-4667371A-87BB-4317-B925-61F06D99E4A5 Q33999756-01E4F315-9C24-4F6A-A7CF-78B81608A24E Q34016211-447B700E-C17A-44A4-8990-19A4AF6F61E6 Q34175370-DA5607CA-20BE-498C-AF06-426976AE8DA5 Q34285680-782871E6-D34A-416B-926B-9007D2C9897E Q34299053-4B8606BB-6AFB-4384-B22E-09EE4B432E6A Q34396095-08DA10BB-99CE-444F-BEBE-FC4C0B4125B1 Q34540645-EB045901-4EAA-4164-9518-80DF6AB9C0EC Q34551010-F143E814-5943-491B-83E9-ED49FF8AB288 Q34555891-4136ED51-2F94-4230-8BD2-405EF76F8725 Q34595009-F5C37420-EF64-410B-9AD8-83047CE37F85 Q34637663-D59B2B25-EA44-409D-9711-B2923502DF0A Q34819651-CD875F75-7B40-4A73-A2A6-DE422477C589 Q34992787-1C817BF4-C585-4ED7-8A3E-58D0B792F883 Q35063075-4557EB7D-2F14-4B84-9BE7-1E15D51D5472 Q35076987-44341703-BA50-454D-82E3-A113906A47A5 Q35092308-F9BC38DE-BF49-4F36-8AFE-6D024C62A43C Q35116581-44A47A3C-E464-406D-9004-14CE666DB981 Q35140429-BC60C3FB-65C9-4BD2-B38E-98FF427FFD91 Q35167400-C81D7928-0563-4D4B-B7E1-7C62967A464C Q35192782-AF41F618-5E00-4D3F-87CC-D3EC16EEA3D5 Q35336374-9B51FBC3-DB55-4A67-99A9-747F19E09C73 Q35735385-D8ECC234-F679-4FC3-830D-0A4A091B47A3

P2860

Role of complex carbohydrates in human immunodeficiency virus type 1 infection and resistance to antibody neutralization

http://www.wikidata.org/entity/Q39723388

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Role of complex carbohydrates ...... nce to antibody neutralization

@en

Role of complex carbohydrates ...... ce to antibody neutralization.

@nl

type

label

Role of complex carbohydrates ...... nce to antibody neutralization

@en

Role of complex carbohydrates ...... ce to antibody neutralization.

@nl

prefLabel

Role of complex carbohydrates ...... nce to antibody neutralization

@en

Role of complex carbohydrates ...... ce to antibody neutralization.

@nl

P1433

Q39723388-E1CB5C8D-3796-455F-83C6-4CD90A346842

P1476

Q39723388-1EDABC56-D07B-4300-8F0F-12345A8D87C7

P2093

Q39723388-0E5E9275-FE54-4BE5-9241-241E25F23780

Q39723388-4183F0A6-E952-4F3D-B822-69FDC0E55ED2

Q39723388-6B154A3E-4AAE-47B3-9167-00D5F6D1AD1D

Q39723388-7C56881D-A4C4-4E7F-B890-9B48E29EEEF4

Q39723388-A9C4EA2D-CAE6-44BA-8C61-1547467CC83D

Q39723388-D462D06F-4A57-4A96-BA1B-6F6A93348CD1

Q39723388-DB8FE9DF-9CEE-4F61-A3D6-E5A01DBCB06C

P2860

Q39723388-06742EC4-60C9-4EB7-B72B-C1AC605217FA

Q39723388-07BA926C-5A9A-43CF-9ED3-451B79DD3D58

Q39723388-0891437D-00B5-470A-BBBE-DCCC161A61DC

Q39723388-0956F819-3EA7-4333-923D-8E31A1AB99EC

Q39723388-0A8B2E82-C34E-41A2-B1A0-A0CE56E8AC39

Q39723388-0AAA0A98-EDBB-42A2-9FF1-47DC5D238009

Q39723388-0C87A166-3FDF-46B6-AA67-83C056B3DEF3

Q39723388-0DED87DC-687E-4A84-B414-0630611128FB

Q39723388-0F21729C-3048-46C1-B3CB-1245DA772C8E

Q39723388-0F805C92-C107-4C88-9AFF-D42834E18DA4

P304

Q39723388-C5DDEFCB-FF00-41A4-9873-50D4956A4B23

P31

Q39723388-FEB27253-EAAB-43F6-B862-C678D7095BC2

P356

Q39723388-3DC6B767-DD7F-4510-98DE-7A7B17797836

P407

Q39723388-01AAA7F9-BB93-4F3F-82B2-B50475A19D87

P433

Q39723388-0C636615-F62B-410D-A7A7-FADAD5FD1728

P478

Q39723388-F46ECC2D-C83D-433B-9DCD-B0837F6E19D7

P577

Q39723388-9C7F380C-C57A-43C2-9A15-7813507E00B3

P698

Q39723388-AB561673-0995-4AF1-87B6-4F255D670BD7

P921

Q39723388-5310995F-89E3-4B15-AB44-5614AEF35193

P932

Q39723388-04FD2CFE-888E-4425-B6C4-CC01F129EA51

P356

P1433

Journal of Virology

P1476

Role of complex carbohydrates ...... nce to antibody neutralization

@en

P2093

Dirk Eggink

http://www.w3.org/2001/XMLSchema#string

Emma T Crooks

http://www.w3.org/2001/XMLSchema#string

James M Binley

http://www.w3.org/2001/XMLSchema#string

Keiko Osawa

http://www.w3.org/2001/XMLSchema#string

Rogier W Sanders

http://www.w3.org/2001/XMLSchema#string

William R Schief

http://www.w3.org/2001/XMLSchema#string

Yih-En Andrew Ban

http://www.w3.org/2001/XMLSchema#string

P2860

Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection

Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies

Inhibition of human immunodeficiency virus syncytium formation and virus replication by castanospermine

Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1

Glycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4 binding

Functional role of the glycan cluster of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) ectodomain

Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1

Structural definition of a conserved neutralization epitope on HIV-1 gp120

Hyperglycosylated mutants of human immunodeficiency virus (HIV) type 1 monomeric gp120 as novel antigens for HIV vaccine design

Infectivities of human and other primate lentiviruses are activated by desialylation of the virion surface

P304

5637-5655

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.00105-10

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

84

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20335257

http://www.w3.org/2001/XMLSchema#string

P921

P932

2876609

http://www.w3.org/2001/XMLSchema#string